Surgalign Embraces New Paradigm for 2021

Surgalign's logo

Surgalign reported 4Q20 orthopedic revenue of USD $26.2 million, -17.1% vs. 4Q19, with full-year 2020 revenue of $101.7 million, -13.3% vs. 2019. In the first full quarter as Surgalign after the sale of RTI’s OEM business, the company faced challenging market dynamics due to the pandemic-related procedure volume decline.

However, the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us